Factors Affecting the Survival of Metastatic Breast Cancer Patients Treated with CDK 4/6 Inhibitors
<i>Background and Objective:</i> We aim to determine the efficacy and the factors associated with the effectiveness of first-line CDK4/6i (ribociclib or palbociclib) treatment in HR-positive, HER2-negative MBC patients. <i>Materials and Methods:</i> This is a retrospective, cross-sectional, and desc...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
MDPI AG
2025-07-01
|
| Schriftenreihe: | Medicina |
| Schlagworte: | |
| Online-Zugang: | https://www.mdpi.com/1648-9144/61/7/1279 |
| Tags: |
Keine Tags, Fügen Sie das erste Tag hinzu!
|